tirzepatide side effects semaglutide side effects comparison vs for Weight Loss in Adults With Overweight or Obesity Tirzepatide vs. Semaglutide: What's the

Weight-Related Outcomes and Adiposity Metrics In the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) trial [61], semaglutide reduced major adverse cardiovascular events by 20% in adults with cardiovascular disease, overweight or obesity, and no diabetes

Protein shakes or smoothies can help meet requirements when solid food feels unappealing, though whole food sources are generally preferable

Effective stroke prevention combines medical interventions, lifestyle adjustments, and a proactive approach to patient care, ensuring the best possible outcomes for AFib patients

Participants on retatrutide 9 mg and 12 mg lost an average of 64.4 lbs (25.9%) and 70.3 lbs (28.3%), respectively, over 80 weeks